Status:

UNKNOWN

The Impact of Robot Assisted Therapy and Metacognitive Skills Training for Children With Hemiparesis

Lead Sponsor:

Boston Children's Hospital

Collaborating Sponsors:

MGH Institute of Health Professions

Conditions:

Hemiparesis

Hemiplegic Cerebral Palsy

Eligibility:

All Genders

7-17 years

Phase:

NA

Brief Summary

The Occupational Therapy Department at Boston Children's Hospital is teaming up with MGH Institute of Health Professions to explore the benefits of using robot assisted therapy (Amadeo) and a problem ...

Detailed Description

Robot assisted therapy and Active Learning Program for Stroke (ALPS) are unique interventions that are feasible and effective for individuals with neuromotor impairments. To the best of our knowledge,...

Eligibility Criteria

Inclusion

  • Child must be between 7 and 17 years of age at the start of the study.
  • Child must have hemiparesis with at least partial active grasp and release.
  • Child must be able to follow multi-step commands.
  • Child must have a caregiver available who can assist with implementation of home exercise program.
  • Child must speak English.
  • Child must have hemiparesis caused by cerebral vascular accident.
  • Child must have adequate insurance to cover evaluation, re-evaluations, and intervention, as this study will be billed to participants' insurance.

Exclusion

  • Child must not have received botulinum toxin or phenol injections within 4 months of and/or during intervention.
  • Child must have tone less than 3/4 on Modified Ashworth Scale.
  • Child must not be considered legally blind.
  • Child must not have contraindications for use of robot assisted device (ie. recent fracture or skin lesion).
  • Child must not be non-verbal.
  • Child must have not had reconstructive surgery to the affected upper extremity within the last year.
  • Child must not be receiving active oncology plan of care.

Key Trial Info

Start Date :

January 11 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2024

Estimated Enrollment :

2 Patients enrolled

Trial Details

Trial ID

NCT04309266

Start Date

January 11 2021

End Date

January 1 2024

Last Update

December 29 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Boston Children's Hospital

Boston, Massachusetts, United States, 02115